US4351826A
(en)
|
1980-02-29 |
1982-09-28 |
Massachusetts Institute Of Technology |
Process for preventing or reversing cataract formation using acrylamides
|
US4526789A
(en)
|
1980-02-29 |
1985-07-02 |
Massachusetts Institute Of Technology |
Process for preventing or reversing cataract formation
|
US4665089A
(en)
|
1985-03-21 |
1987-05-12 |
Massachusetts Institute Of Technology |
Process for preventing or reversing cataract formation using protein modification reagents
|
US4620979A
(en)
*
|
1985-08-02 |
1986-11-04 |
Schachar Ronald A |
Ophthalmological irrigating solution containing ascorbate
|
US4771036A
(en)
|
1986-02-10 |
1988-09-13 |
Trustees Of Columbia University In The City Of New York |
Method and ophthalmic composition for the prevention and reversal of cataracts
|
US5055291A
(en)
|
1986-11-04 |
1991-10-08 |
Baylor College Of Medicine |
Compositions for preventing secondary cataracts
|
US4808182A
(en)
*
|
1986-11-26 |
1989-02-28 |
Nestle, S.A. |
Deswelled, hydrogel intraocular lenses
|
US5091421A
(en)
|
1987-06-04 |
1992-02-25 |
Massachusetts Institute Of Technology |
Chemical prevention or reversal of cataract by phase separation inhibitors
|
US5338545A
(en)
|
1987-06-04 |
1994-08-16 |
Oculon Corporation |
Chemical prevention or reversal of cataract by phase separation inhibitors
|
JPH0262821A
(ja)
*
|
1988-08-27 |
1990-03-02 |
Santen Pharmaceut Co Ltd |
抗白内障剤
|
DE3906311A1
(de)
*
|
1989-02-28 |
1990-08-30 |
Adatomed Pharma & Med |
Behandlungsystem zur verhinderung von nachstarbildung nach einer kataraktoperation
|
JP2515394B2
(ja)
*
|
1989-03-31 |
1996-07-10 |
帝人株式会社 |
γ―L―グルタミル―L―システインエステル誘導体を含有するリポソ―ム製剤
|
WO1992000748A1
(en)
|
1990-07-06 |
1992-01-23 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
ATE138914T1
(de)
|
1990-12-10 |
1996-06-15 |
Bio Physio Pharmaceutical Rese |
Indeno-d-pyrimidonverbindungen zur verwendung in der medizin
|
PL171704B1
(pl)
|
1992-05-20 |
1997-06-30 |
Senju Pharma Co |
Sposób wytwarzania srodka farmaceutycznego do leczenia lub profilaktyki zacmy PL
|
CN1045383C
(zh)
*
|
1993-04-07 |
1999-10-06 |
王慧康 |
用于治疗老年性白内障的药物组合物
|
US5663304A
(en)
*
|
1993-08-20 |
1997-09-02 |
Genentech, Inc. |
Refolding of misfolded insulin-like growth factor-I
|
WO1995013827A1
(en)
|
1993-11-19 |
1995-05-26 |
The University Of Sydney |
A method for preventing or controlling cataract
|
US5516534A
(en)
*
|
1993-11-26 |
1996-05-14 |
Rensselaer Polytechnic Institute |
Composition and method for reducing structural defects
|
US5591773A
(en)
|
1994-03-14 |
1997-01-07 |
The Trustees Of Columbia University In The City Of New York |
Inhibition of cataract formation, diseases resulting from oxidative stress, and HIV replication by caffeic acid esters
|
WO1995031223A1
(fr)
|
1994-05-13 |
1995-11-23 |
Kuraray Co., Ltd. |
Gel polymere a usage medical
|
EP0733918B1
(en)
|
1995-03-24 |
2003-07-30 |
Ocular Research of Boston, Inc. |
Hydrogel lens pre-coated with lipid layer
|
JP3599848B2
(ja)
|
1995-09-11 |
2004-12-08 |
株式会社メニコン |
含水性軟質眼用レンズ用材料、それからなる含水性軟質眼用レンズ用成形体、ならびにそれからなる含水性軟質眼用レンズおよびその製法
|
IT1277707B1
(it)
*
|
1995-12-22 |
1997-11-11 |
Chemedica Sa |
Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
|
EP0781777A1
(en)
|
1995-12-28 |
1997-07-02 |
Menicon Co., Ltd. |
Silicon-containing compound and ocular lens material
|
EP0816398B1
(en)
|
1996-06-28 |
2002-08-14 |
Ube Industries, Ltd. |
Process for producing polybutadiene
|
US5817630A
(en)
*
|
1997-03-18 |
1998-10-06 |
Austin Nutriceutical Corporation |
Glutathione antioxidant eye drops
|
JPH10339857A
(ja)
|
1997-06-05 |
1998-12-22 |
Menicon Co Ltd |
薬剤徐放性コンタクトレンズの製法およびそれによってえられた薬剤徐放性コンタクトレンズ
|
US6015787A
(en)
|
1997-11-04 |
2000-01-18 |
New England Medical Center Hospitals, Inc. |
Cell-permeable protein inhibitors of calpain
|
US6291466B1
(en)
*
|
1998-07-30 |
2001-09-18 |
Allergan Sales, Inc. |
Cholinergic agents in the treatment of presbyopia
|
EP1149909A1
(en)
|
2000-04-28 |
2001-10-31 |
Boehringer Mannheim Gmbh |
Methods for regulating protein conformation using molecular chaperones
|
US6103756A
(en)
|
1999-08-11 |
2000-08-15 |
Vitacost Inc. |
Ocular orally ingested composition for prevention and treatment of individuals
|
CA2389917A1
(en)
|
1999-11-04 |
2001-05-10 |
Kazunori Kataoka |
A polymer micelle as monolayer or layer-laminated surface
|
US6835394B1
(en)
|
1999-12-14 |
2004-12-28 |
The Trustees Of The University Of Pennsylvania |
Polymersomes and related encapsulating membranes
|
US7977385B2
(en)
*
|
2000-03-02 |
2011-07-12 |
Numoda Biotechnologies, Inc. |
Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
|
US7833977B2
(en)
|
2000-12-15 |
2010-11-16 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Use of L-Carnitine as stabilizing agent of proteins
|
US6958224B2
(en)
|
2001-03-28 |
2005-10-25 |
Council Of Scientific And Industrial Research |
Chimeric protein α BNAC crystallin with extraordinarily high chaperone-like activity and a method related to the use thereof
|
US20030020870A1
(en)
|
2001-06-27 |
2003-01-30 |
Zms, Llc |
Biomedical molding materials from semi-solid precursors
|
US20050260259A1
(en)
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
JP2004161731A
(ja)
|
2002-09-25 |
2004-06-10 |
Nof Corp |
生体関連物質用固定化剤
|
CN1471924A
(zh)
*
|
2003-07-09 |
2004-02-04 |
吕家昌 |
一种有助于老花眼视力恢复的药液
|
CN1621091A
(zh)
|
2003-11-28 |
2005-06-01 |
付经国 |
聚乙二醇化轮状病毒体肠靶向制剂及其合成方法
|
WO2005110375A1
(en)
|
2004-05-08 |
2005-11-24 |
Paul Edward L Jr |
Nutritional supplement for treatment of ocular diseases
|
WO2005117987A1
(en)
|
2004-06-01 |
2005-12-15 |
Glazier Alan N |
Antibody conjugates targeting to ocular proteins
|
US6945971B1
(en)
|
2004-07-19 |
2005-09-20 |
Gwon Arlene E |
Controlled ocular lens regeneration
|
US20080227700A1
(en)
|
2004-11-04 |
2008-09-18 |
Ghosh Joy G |
Compositions and Methods for Treatment of Protein Misfolding and Protein Aggregation Diseases
|
US7741311B2
(en)
|
2005-01-03 |
2010-06-22 |
Shaker Mousa |
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
|
CN1660920A
(zh)
|
2005-02-01 |
2005-08-31 |
华东理工大学 |
末端连接ω-氨基酸的聚乙二醇酸或活性酯及制法和应用
|
DE102005041570A1
(de)
|
2005-09-01 |
2007-03-22 |
Celares Gmbh |
Hoch verzweigte Reagenzien zur Modifaktion von Biopharmazeutika, deren Herstellung und Anwendung
|
US7832875B2
(en)
*
|
2005-09-29 |
2010-11-16 |
Virtek Vision International Inc. |
Modulated diode pumped microchip laser projector
|
US20070275098A1
(en)
*
|
2006-05-19 |
2007-11-29 |
T.R.P. Company, Inc, A Nevada Corporation |
Formulation and methodology for the treatment for eye impairment symptoms
|
WO2008145721A2
(en)
|
2007-06-01 |
2008-12-04 |
Novo Nordisk A/S |
N-terminal modification of polypeptides for protection against degradation by aminopeptidases
|
WO2009029991A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Meat & Livestock Australia Limited |
Agents with angiogenic and wound healing activity
|
CN103120690A
(zh)
|
2007-10-19 |
2013-05-29 |
株式会社·R-技术上野 |
用于治疗白内障的药物组合物
|
KR20100000203A
(ko)
|
2008-06-24 |
2010-01-06 |
인하대학교 산학협력단 |
금나노입자를 이용한 표적지향형 항암약물전달체
|
BRPI0913653A2
(pt)
*
|
2008-06-30 |
2015-10-20 |
Johnson & Johnson Vision Care |
métodos e dispositivos oftálmicos usados no tratamento de alergias oculares
|
BRPI0823084B1
(pt)
|
2008-07-14 |
2019-07-16 |
Biocon Limited |
Método de síntese de uma mistura de oligômeros substancialmente monodispersa
|
WO2010065024A1
(en)
|
2008-12-05 |
2010-06-10 |
Kador Peter F |
Topical treatment of cataracts in dogs
|
WO2010130638A1
(en)
|
2009-05-14 |
2010-11-18 |
Evotec Ag |
Sulfonamide compounds, pharmaceutical compositions and uses thereof
|
CN102634492B
(zh)
|
2011-02-14 |
2015-06-10 |
重庆富进生物医药有限公司 |
聚乙二醇化犬源尿酸氧化酶类似物及其制备方法和应用
|
CN103918055B
(zh)
|
2011-03-31 |
2016-08-17 |
Dh科技发展私人贸易有限公司 |
用于校准质谱仪的组合物、方法和试剂盒
|
CN102579353B
(zh)
|
2012-03-30 |
2013-12-04 |
吉林大学 |
叶酸靶向的抗癌药物peg修饰的脂质体及制备方法
|